All Disease Treatment & Prevention articles – Page 9
-
NewsStable RNA elements open new possibilities for mRNA therapeutics
New research has discovered compact viral RNA elements that can make mRNA more stable, and could provide a simple way to develop longer-lasting and more efficient mRNA technologies for vaccines and other RNA-based therapeutics.
-
NewsCells use a little-known molecule to protect themselves from iron overload
New research shows that cells rely on an unexpected protector against elevated iron levels: small molecules called polyamines. These small molecules act like storage lockers for iron, safely holding the metal in a non-reactive state until cells need it.
-
NewsNovel AI model accurately detects key gene mutations and predicts biomarkers across 32 cancer types
Researchers have developed a novel AI model capable of predicting cancer subtypes, specific genetic mutations, and survival outcomes across 32 different cancers.
-
NewsImmune molecules play a limited role in ALS progression
New research indicates that immune-related molecules change in motor neurons affected by amyotrophic lateral sclerosis (ALS), but they do not appear to be major drivers of disease progression.
-
NewsPregnancy increases immune burden on women with arthritis and lupus
New research finds that the immune system of women with autoimmune diseases such as rheumatoid arthritis and lupus react very differently to pregnancy: rheumatoid arthritis patients often experience an improvement in symptoms, while lupus patients have an elevated risk of deterioration.
-
NewsCould preventing shingles also help prevent dementia?
A new study finds that older adults who received a shingles vaccine had a 24% lower risk of developing dementia over four years. The findings add to growing evidence that preventing shingles may also protect against neurological disease.
-
NewsWorld’s first oral microbiome-based nanomedicine to supercharge anti-cancer immunity
Researchers have successfully developed the world’s first oral, microbiome-based nanomedicine which enhances the ability of immune cells to attack cancer cells.
-
NewsSteroids reduce inflammation in chronic mycobacterial lung infections without limiting antimicrobial defence
Researchers have shown that dexamethasone, a commonly prescribed anti-inflammatory steroid, can reduce harmful inflammation triggered by Mycobacterium avium without weakening the ability of human immune cells to control the infection.
-
NewsAncient bacterial signals from cell powerhouses may fuel excessive inflammation
Researchers have discovered that proteins released from mitochondria can activate the immune system in a similar way to invading bacteria, suggesting that remnants of mitochondria’s evolutionary past may contribute to inflammation.
-
NewsLong-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
-
NewsTriple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
-
NewsNew viral marker strategies improve prediction of functional cure in chronic hepatitis B
Researchers identify how combining classical and emerging viral biomarkers can better predict functional cure and guide individualized hepatitis B treatment.
-
NewsWhen fever isn’t the answer: Infected tadpoles cool themselves to fight viruses
Researchers have experimentally demonstrated that an ectothermic vertebrate infected with a virus actively seeks cooler, rather than warmer, environments to regulate its body temperature.
-
NewsStudy finds HIV-1 proviruses may drive chronic systemic inflammation
People living with HIV are at higher risk of developing inflammatory diseases of many tissues, even when receiving antiviral treatments. A new study suggests that persistent hidden HIV contributes to this inflammation.
-
NewsObesity drug significantly reduces the risk of infections and serious cardiovascular events
Tirzepatide, marketed under the brand name Mounjaro, could reduce the risk of heart attacks and hospitalizations due to infections in people with type 2 diabetes by by about one-third when compared with a conventional diabetes medication.
-
NewsResearchers uncover unexpected twist in fight against antibiotic resistance
A group of Cornell College students and their professor have discovered surprising results in their research on antimicrobial peptides, which are being studied as a method of combating antibiotic resistance.
-
NewsMeningococcal B vaccine linked to lower gonorrhoea risk
The meningococcal B vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in young people in Australia.
-
NewsResearchers develop new drug to attack an enduring killer
Researchers have developed a new antimalarial drug designed to thwart even the most drug-resistant forms of the infection.
-
NewsLong non-coding RNAs offer new hope for earlier detection and improved treatment of liver cancer linked to hepatitis B
Long non-coding RNAs may play a pivotal role in shaping the future of diagnosis, prognosis, and treatment in HBV-associated liver disease.
-
NewsAdults living with HIV are at high risk for diabetes. Here’s why.
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.